Back to mobile site

Amarin (AMRN) AMR101 MARINE Phase 3 Trial Meets Endpoints

November 29, 2010 6:39 AM EST Send to a Friend
Amarin Corporation plc (Nasdaq: AMRN) reported positive, statistically significant top-line results from the MARINE study, its first Phase 3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login